Form 8-K - Current report:
SEC Accession No. 0001213900-19-025202
Filing Date
2019-12-03
Accepted
2019-12-03 16:03:48
Documents
32
Period of Report
2019-11-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k112719_relmada.htm 8-K 41772
2 AMENDED AND RESTATED UNIT PURCHASE AGREEMENT DATED NOVEMBER 27, 2019, BETWEEN RE f8k112719ex10-1_relmada.htm EX-10.1 233278
3 AMENDMENT NO.1 TO LICENSE AGREEMENT DATED DECEMBER 2, 2019, TO THE LICENSE AGREE f8k112719ex10-2_relmada.htm EX-10.2 21636
4 UPDATED BUSINESS, DIRECTORS AND EXECUTIVE OFFICERS AND CERTAIN RELATIONSHIPS AND f8k112719ex99-1_relmada.htm EX-99.1 266850
5 UPDATED RISK FACTORS f8k112719ex99-2_relmada.htm EX-99.2 327143
6 CORPORATE PRESENTATION, DATED DECEMBER 2019 f8k112719ex99-3_relmada.htm EX-99.3 31839
7 GRAPHIC ex99-3_001.jpg GRAPHIC 373183
8 GRAPHIC ex99-3_002.jpg GRAPHIC 171561
9 GRAPHIC ex99-3_003.jpg GRAPHIC 187249
10 GRAPHIC ex99-3_004.jpg GRAPHIC 266147
11 GRAPHIC ex99-3_005.jpg GRAPHIC 193297
12 GRAPHIC ex99-3_006.jpg GRAPHIC 244957
13 GRAPHIC ex99-3_007.jpg GRAPHIC 93297
14 GRAPHIC ex99-3_008.jpg GRAPHIC 186009
15 GRAPHIC ex99-3_009.jpg GRAPHIC 179323
16 GRAPHIC ex99-3_010.jpg GRAPHIC 223069
17 GRAPHIC ex99-3_011.jpg GRAPHIC 256085
18 GRAPHIC ex99-3_012.jpg GRAPHIC 177854
19 GRAPHIC ex99-3_013.jpg GRAPHIC 249143
20 GRAPHIC ex99-3_014.jpg GRAPHIC 248853
21 GRAPHIC ex99-3_015.jpg GRAPHIC 182751
22 GRAPHIC ex99-3_016.jpg GRAPHIC 162030
23 GRAPHIC ex99-3_017.jpg GRAPHIC 239244
24 GRAPHIC ex99-3_018.jpg GRAPHIC 131228
25 GRAPHIC ex99-3_019.jpg GRAPHIC 142471
26 GRAPHIC ex99-3_020.jpg GRAPHIC 113279
27 GRAPHIC ex99-3_021.jpg GRAPHIC 161686
28 GRAPHIC ex99-3_022.jpg GRAPHIC 126596
29 GRAPHIC ex99-3_023.jpg GRAPHIC 47404
30 GRAPHIC ex99-3_024.jpg GRAPHIC 187358
31 GRAPHIC ex99-3_025.jpg GRAPHIC 163681
32 GRAPHIC ex99-3_026.jpg GRAPHIC 373183
  Complete submission text file 0001213900-19-025202.txt   7924546
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39082 | Film No.: 191265844
SIC: 2834 Pharmaceutical Preparations